148 related articles for article (PubMed ID: 19017554)
1. Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging.
Sijens PE; Mostert JP; Irwan R; Potze JH; Oudkerk M; De Keyser J
Psychiatry Res; 2008 Dec; 164(3):274-82. PubMed ID: 19017554
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
Mostert JP; Sijens PE; Oudkerk M; De Keyser J
Neurosci Lett; 2006 Jul; 402(1-2):22-4. PubMed ID: 16644118
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
4. Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI,
Cambron M; Reynders T; Debruyne J; Reyngoudt H; Ribbens A; Achten E; Laureys G
J Neurol; 2018 Nov; 265(11):2614-2624. PubMed ID: 30187159
[TBL] [Abstract][Full Text] [Related]
5. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
6. Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
Wiebenga OT; Klauser AM; Schoonheim MM; Nagtegaal GJ; Steenwijk MD; van Rossum JA; Polman CH; Barkhof F; Pouwels PJ; Geurts JJ
AJNR Am J Neuroradiol; 2015 Jun; 36(6):1116-23. PubMed ID: 25742985
[TBL] [Abstract][Full Text] [Related]
7. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
8. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
[TBL] [Abstract][Full Text] [Related]
9. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS.
Assaf Y; Chapman J; Ben-Bashat D; Hendler T; Segev Y; Korczyn AD; Graif M; Cohen Y
Magn Reson Imaging; 2005 Jul; 23(6):703-10. PubMed ID: 16198825
[TBL] [Abstract][Full Text] [Related]
10. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
11. Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
Cader S; Johansen-Berg H; Wylezinska M; Palace J; Behrens TE; Smith S; Matthews PM
Neuroimage; 2007 May; 36(1):19-27. PubMed ID: 17398118
[TBL] [Abstract][Full Text] [Related]
12. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
Vrenken H; Pouwels PJ; Geurts JJ; Knol DL; Polman CH; Barkhof F; Castelijns JA
J Magn Reson Imaging; 2006 May; 23(5):628-36. PubMed ID: 16565955
[TBL] [Abstract][Full Text] [Related]
13. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Oh J; Pelletier D; Nelson SJ
Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
Zhou F; Shiroishi M; Gong H; Zee CS
J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
[TBL] [Abstract][Full Text] [Related]
15. MR spectroscopy and diffusion tensor imaging of the brain in congenital muscular dystrophy with merosin deficiency: metabolite level decreases, fractional anisotropy decreases, and apparent diffusion coefficient increases in the white matter.
Sijens PE; Fock JM; Meiners LC; Potze JH; Irwan R; Oudkerk M
Brain Dev; 2007 Jun; 29(5):317-21. PubMed ID: 17113260
[TBL] [Abstract][Full Text] [Related]
16. Effects of fluoxetine on the amygdala and the hippocampus after administration of a single prolonged stress to male Wistar rates: In vivo proton magnetic resonance spectroscopy findings.
Han F; Xiao B; Wen L; Shi Y
Psychiatry Res; 2015 May; 232(2):154-61. PubMed ID: 25841890
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.
Bodini B; Branzoli F; Poirion E; García-Lorenzo D; Didier M; Maillart E; Socha J; Bera G; Lubetzki C; Ronen I; Lehericy S; Stankoff B
Mult Scler; 2018 Mar; 24(3):313-321. PubMed ID: 28394203
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
Wood ET; Ercan E; Sati P; Cortese ICM; Ronen I; Reich DS
Neuroimage Clin; 2017; 15():780-788. PubMed ID: 28702353
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
[TBL] [Abstract][Full Text] [Related]
20. Diffusion tensor imaging and magnetic resonance spectroscopy of the brain in a patient with Sturge-Weber syndrome.
Sijens PE; Gieteling EW; Meiners LC; Sival DA; Potze JH; Irwan R; Oudkerk M
Acta Radiol; 2006 Nov; 47(9):972-6. PubMed ID: 17077050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
